GSI 7977 (Sovaldi 400 mg)

Generic Name: sofosbuvir

Pill imprint GSI 7977 has been identified as Sovaldi 400 mg.

Sovaldi is used in the treatment of hepatitis c and belongs to the drug class miscellaneous antivirals. There is no proven risk in humans during pregnancy. In combination with Ribavirin or Peginterferon Alfa/Ribavirin: Not for use in pregnancy. Sovaldi 400 mg is not a controlled substance under the Controlled Substance Act (CSA).

Sovaldi

Generic Name:

sofosbuvir

Imprint:

GSI 7977

Strength:

400 mg

Color:

Yellow

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Miscellaneous antivirals

Pregnancy Category:

B - No proven risk in humans
X - Not for use in pregnancy - in combination with Ribavirin or Peginterferon Alfa/Ribavirin

CSA Schedule:

Not a controlled drug

Manufacturer:

Gilead Sciences, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.